N-(5beta-cholan-24-oyl)-L-beta-homo-tryptophan

ID: ALA4059908

PubChem CID: 137637448

Max Phase: Preclinical

Molecular Formula: C36H52N2O3

Molecular Weight: 560.82

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CCCC[C@]4(C)[C@H]3CC[C@]12C

Standard InChI:  InChI=1S/C36H52N2O3/c1-23(11-16-33(39)38-26(21-34(40)41)20-24-22-37-32-10-5-4-9-27(24)32)29-14-15-30-28-13-12-25-8-6-7-18-35(25,2)31(28)17-19-36(29,30)3/h4-5,9-10,22-23,25-26,28-31,37H,6-8,11-21H2,1-3H3,(H,38,39)(H,40,41)/t23-,25+,26+,28+,29-,30+,31+,35+,36-/m1/s1

Standard InChI Key:  WCINYUWYVYOZNR-MAAFBQBVSA-N

Molfile:  

     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
   28.6141  -10.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6141  -11.7832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3194  -12.1877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3194  -10.5533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0246  -10.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0257  -11.7832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7300  -12.1887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4378  -11.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7279  -10.5543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4387  -10.9649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4374   -9.3261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7242   -9.7357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1482   -9.7367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1451  -10.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9255  -10.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4110  -10.1523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9305   -9.4858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0173  -10.1489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0215  -12.5963    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   30.7231  -11.3705    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.4330  -10.1447    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   32.1387  -11.3746    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   32.1429   -8.9189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1860   -8.7096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9859   -8.5427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6414   -8.1003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5305   -9.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3304   -8.9851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5859   -8.2089    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.7153   -9.2698    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   35.8750   -9.5945    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.6749   -9.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9304   -8.6513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7303   -8.4844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9858   -7.7082    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.2749   -9.0937    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.2194  -10.0369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9640  -10.8131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1864  -11.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1834  -11.8795    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.4424  -11.4756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9590  -12.1311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2851  -12.8753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0943  -12.9653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5763  -12.3050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2476  -11.5634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9 10  1  0
  9 12  1  0
 10 14  1  0
 13 11  1  0
 11 12  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
  5 18  1  1
  6 19  1  1
  9 20  1  6
 10 21  1  1
 14 22  1  6
 13 23  1  1
 17 24  1  0
 24 25  1  0
 24 26  1  6
 25 27  1  0
 27 28  1  0
 28 29  2  0
 17 30  1  6
 28 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 32 37  1  6
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 42  1  0
 41 38  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 45  1  0
 45 46  2  0
 46 41  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4059908

    ---

Associated Targets(Human)

EPHA2 Tclin Ephrin type-A receptor 2 (3499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Epha2 Ephrin type-A receptor 2 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 560.82Molecular Weight (Monoisotopic): 560.3978AlogP: 8.14#Rotatable Bonds: 9
Polar Surface Area: 82.19Molecular Species: ACIDHBA: 2HBD: 3
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.57CX Basic pKa: CX LogP: 7.71CX LogD: 4.96
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.29Np Likeness Score: 1.22

References

1. Incerti M, Russo S, Callegari D, Pala D, Giorgio C, Zanotti I, Barocelli E, Vicini P, Vacondio F, Rivara S, Castelli R, Tognolini M, Lodola A..  (2017)  Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.,  60  (2): [PMID:28005388] [10.1021/acs.jmedchem.6b01642]
2. Lodola A, Giorgio C, Incerti M, Zanotti I, Tognolini M..  (2017)  Targeting Eph/ephrin system in cancer therapy.,  142  [PMID:28780190] [10.1016/j.ejmech.2017.07.029]

Source